The Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of Technology, University Heights, Newark, USA.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):889-97. doi: 10.1016/j.ejpb.2013.03.025. Epub 2013 Apr 3.
A simple, sensitive, efficient, and novel method analyzing the number of spherulitic nuclei was proposed to estimate the solubility of a model drug acetaminophen (APAP) in poly(ethylene oxide) (PEO). At high crystallization temperature (323 K), 10% APAP-PEO had the same low number of spherulitic nuclei as pure PEO, indicating that APAP and PEO were fully miscible. At low crystallization temperature (303 K), the number of nuclei for 10% APAP-PEO was significantly higher, suggesting that APAP was oversaturated and therefore recrystallized and acted as a nucleating agent. Based on the results obtained, the solubility of APAP in PEO is possibly between the concentration of 0.1% and 1% at 303 K. The spherulitic growth rate G of PEO was found to decrease with increasing APAP concentration, suggesting that APAP is most likely functioning as a chemical defect and is either rejected from or included in the PEO crystals during chain folding. APAP could possibly locate in the inter-spherulitic, inter-fibrillar, inter-lamellar, or intra-lamellar regions of PEO. At 323 K, the morphology of 10% APAP-PEO is more dendritic than spherulitic with large unfilled space in between dendrites and spherulites, which is a sign of one or the combination of the four modes of segregation. An extensive spherulitic nucleation and growth kinetics study using the classical theoretical relationships, for example, the Hoffman-Lauritzen (HL) and Avrami theories, was conducted. Both microscopic and differential scanning calorimetric (DSC) analysis yielded similar values for the nucleation constant Kg as well as the fold surface free energy σe and work of chain folding q. The values of σe and q increased with APAP concentration, indicating that the chain folding of PEO was hindered by APAP.
提出了一种简单、灵敏、高效且新颖的方法来分析球晶核数量,以估计模型药物对乙酰氨基酚(APAP)在聚环氧乙烷(PEO)中的溶解度。在高结晶温度(323 K)下,10%APAP-PEO 的球晶核数量与纯 PEO 相同,表明 APAP 和 PEO 完全混溶。在低结晶温度(303 K)下,10%APAP-PEO 的核数显著增加,表明 APAP 过饱和,因此重结晶并充当成核剂。基于所得结果,APAP 在 PEO 中的溶解度在 303 K 时可能在 0.1%到 1%之间。发现 PEO 的球晶生长速率 G 随 APAP 浓度的增加而降低,表明 APAP 最有可能作为化学缺陷存在,在链折叠过程中被 PEO 晶体排斥或包含。APAP 可能位于 PEO 的球晶间、纤维间、层间或层内区域。在 323 K 时,10%APAP-PEO 的形态比球晶更具树枝状,树枝状和球晶之间有很大的未填充空间,这是一种或四种分离模式的组合的迹象。使用经典理论关系(例如 Hoffman-Lauritzen(HL)和 Avrami 理论)进行了广泛的球晶成核和生长动力学研究。微观和差示扫描量热法(DSC)分析都得出了相似的成核常数 Kg 以及折叠表面自由能 σe 和链折叠功 q 的值。σe 和 q 的值随 APAP 浓度的增加而增加,表明 PEO 的链折叠受到 APAP 的阻碍。